A naukri.com initiative
Analyticsindiamag
3w
218
Image Credit: Analyticsindiamag
This NVIDIA-Backed AI Startup Could Change the Way We Discover New Drugs
- SandboxAQ, an AI startup backed by NVIDIA, aims to enhance drug discovery by assisting in predicting the effectiveness of drugs attaching to proteins.
- The company has raised $150 million from investors like Google, NVIDIA, and BNP Paribas, increasing its Series E round to $450 million and valuing the startup at $5.75 billion.
- Google and NVIDIA have been investing in quantum computing, with SandboxAQ leveraging NVIDIA's processors to create large quantitative models for data analysis.
- SandboxAQ's AI models may revolutionize drug discovery and financial modeling, offering predictive insights for researchers using their platforms like Google Cloud.
- The company generated synthetic data using NVIDIA's processors to aid in predicting drug-protein interactions, aiming to accelerate the drug development process.
- SandboxAQ's approach integrates AI with scientific computing to handle complex molecular calculations, providing fast and accurate results compared to traditional methods.
- The AI startup's models aim to predict the adherence of new drug molecules to targeted proteins quickly and accurately, streamlining drug development.
- SandboxAQ addresses the limitations of large language models, offering precise simulations for drug discovery and development processes.
- The company provides end-to-end support in the drug discovery lifecycle, from target identification to toxicity prediction, accelerating decision-making.
- With a focus on optimising AI solutions for drug discovery, SandboxAQ could potentially transform how new drugs are developed and validated.
Read Full Article
13 Likes
For uninterrupted reading, download the app